Treatment options when breast cancer becomes unresponsive to chemotherapy
UC expert speaks with Everyday Health
The University of Cincinnati's Mahmoud Charif was featured in an Everyday Health article discussing treatment options when metastatic triple-negative breast cancer (mTNBC) becomes unresponsive to chemotherapy.
Even though chemotherapy is the standard treatment for mTNBC, it’s not uncommon for these drugs to stop working eventually.
Charif, MD, a University of Cincinnati Cancer Center member, associate professor in the UC College of Medicine and a UC Health physician, said breast cancer cells can become resistant to chemotherapy over time, making the treatment less effective. This is especially the case for mTNBC, which is typically a more aggressive form of cancer.
Treatment options when mTNBC becomes unresponsive to chemotherapy include immunotherapy, clinical trials and a class of drugs called antibody-drug conjugates (ADCs). Charif explained ADCs combine an antibody therapy and chemotherapy to work together to kill cancer cells.
Read the Everyday Health article.
Featured photo of 3D breast cancer cell courtesy of the National Cancer Institute.
Related Stories
What Is Public Health Nursing? Career path and whether it’s right for you
April 6, 2026
When nurses consider graduate school, many immediately think of becoming a nurse practitioner. But there is another advanced path that is growing in demand, one focused not on treating individual patients, but on improving the health of entire communities: public health nursing.
What is the 'cicada' COVID variant?
April 6, 2026
A formerly rare strain of COVID, BA.3.2, now is showing up in Ohio and 24 other states. Experts say so far it hasn't caused illness any more severe than other strains, but it might be somewhat more resistant to vaccines, as 91.7 WVXU News recently reported. Scientists have nicknamed the variant "cicada" due to its former low profile and current resurgence.
UC opens zebrafish research facility to study infertility
April 6, 2026
The University of Cincinnati is launching a state-of-the-art zebrafish research facility that scientists say could help explain how environmental toxins affect fertility, as WKRC-TV/Local 12 and WLWT-TV/Ch. 5 recently reported.